Skip to main content

Table 2 Distance to 50% reduction in prevalence and global study prevalence across the studies

From: The spatial signature of Plasmodium vivax and Plasmodium falciparum infections: quantifying the clustering of infections in cross-sectional surveys and cohort studies

Study type

Study site

P. falciparum

P. vivax

Global study prevalence (%)

Distance to 50% reduction in prevalence

Global study prevalence (%)

Distance to 50% reduction in prevalence

Cross-sectional surveys

Cambodia

3.0

975 m

6.4

875 m

Thailand

1.1

75 m

3.3

25 m

Brazil Survey 1

–

–

4.2

175 m

Brazil Survey 2

–

–

3.6

75 m

Solomon Islands

0.2

75 m

13.9

3175 m

Cohort studies

Thailand

–

–

2.4

75 m

Brazil

–

–

2.6

75 m

  1. From the spatial signatures (for cross-sectional surveys) or spatiotemporal signatures at time window of ‘0 months’, i.e. the same month (for cohort studies) for P. vivax and P. falciparum
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us